A glucocorticoid receptor-independent mechanism for neurosteroid inhibition of tumor necrosis factor production

European Journal of Pharmacology

Volumn 299, Issue 1-3, 1996, Pages 179-186

  Di Santo, Elena ^a   Sironi, Marina ^a   Mennini, Tiziana ^a   Zinetti, Mirella ^a   Savoldi, Gianfranco ^b   Di Lorenzo, Diego ^b   Ghezzi, Pietro ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b CNR   (Italy)

Author keywords

Dehydroepiandrosterone sulfate; Glucocorticoid; Neurosteroid; Pregnenolone; TNF (tumor necrosis factor)

Indexed keywords

CORTICOSTERONE; DEXAMETHASONE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; MESSENGER RNA; MIFEPRISTONE; NEUROSTEROID; OROSOMUCOID; PRASTERONE SULFATE; PREGNENOLONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; HUMAN; HUMAN CELL; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0029912150     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00840-3     Document Type: Article

References (32)

1. Aggarwal, B.B., W.J. Khor, P.E. Hass, B. Moffat, S.A. Spencer, J. Henzel, S. Bringman, G.E. Nedwin, D.V. Goeddel and R.N. Harkins, 1985, Human tumor necrosis factor. Production, purification and characterization, J. Biol. Chem. 260, 2345.
2. Bertini, R., M. Bianchi and P. Ghezzi, 1988, Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor, J. Exp. Med. 167, 1708.
3. Besedovsky, H., A. Del Rey and C.A. Dinarello, 1986, Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones, Science 233, 652.
4. Beutler, B., N. Krochin, I.W. Milsark, C. Luedke and A. Cerami, 1986, Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance, Science 232, 977.
5. Blauer, K.L., M. Poth, W.M. Rogers and E.W. Bernton, 1991, Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation, Endocrinology 129, 3174.
6. Catania, A. and J.M. Lipton, 1993, Alpha-melanocyte stimulating hormone in the modulation of host reactions, Endocrine Rev. 14, 564.
7. Chirgwin, J.H., A.E. Prybyla, R.J. MacDonald and J. Rutter, 1979, Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochemistry 18, 5294.
8. Chrousos, G.P., 1995, The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation, New Engl. J. Med. 332, 1351.
9. Corpéchot, C., P. Robel, M. Axelson, J. Sjövall and E.-E. Baulieu, 1981, Characterization and measurement of dehydroepiandrosterone sulfate in rat brain, Proc. Natl. Acad. Sci. USA 78, 4704.
10. Corpéchot, C., M. Singuelakis, S. Talha, M. Axelson, J. Sjövall, R. Vihko, E.-E. Baulieu and P. Robel, 1983, Pregnenolone and its sulfate ester in the rat brain, Brain Res. 270, 119.
11. Corti, A., G. Fassina, F. Marcucci, E. Barbanti and G. Cassani, 1992, Oligomeric tumor necrosis factor a slowly converts into inactive forms at bioactive levels, Biochem. J. 284, 905.
12. Danenberg, H.D., G. Alpert, S.G. Lustig and D. Ben-Nathan, 1992, Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production, Antimicrob. Agents Chemother. 36, 2275.
13. Daynes, R.D., D.J. Dudley and B.A. Araneo, 1990, Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells, Eur. J. Immunol. 20, 793.
14. De Boer, M., R. Reijneke, R.J. Van de Griend, J.A. Loos and D. Roos, 1981, Large-scale purification and cryopreservation of human monocytes, J. Immunol. Methods 43, 225.
15. Fantuzzi, G. and P. Ghezzi, 1993, Glucocorticoids as cytokine inhibitors: role in neuroendocrine control and therapy of inflammatory diseases, Mediat. Inflamm. 2, 263.
16. Fantuzzi, G., M.T. Demitri and P. Ghezzi, 1994, Differential effect of glucocorticoids on tumor necrosis factor production in mice: upregulation by early pretreatment with dexamethasone, Clin. Exp. Immunol. 96, 166.
17. Gnocchi, P., C. Losa, D. Trizio and A.M. Isetta, 1992, Development and application of a radioimmunoassay (RIA) for the in vitro and in vivo quantification of murine IL-1β, Lymphokine Cytokine Res. 11, 257.
18. Haley, T.J. and W.G. McCormick, 1957, Pharmacological effects produced by intracerebral injection of drugs in the conscious mice, Br. J. Pharmacol. 12, 12.
19. Hawes, A.S., C.S. Rock, C.V. Keogh, S.F. Lowry and S.E. Calvano, 1992, In vivo effects of the antiglucocorticoid RU 486 on glucocorticoid and cytokine response to Escherichia coli endotoxin, Infect. Immunol. 60, 2641.
20. Haynes, R.C., 1990, Adrenocorticotropic hormone, adrenocortical steroids and their synthetic analogs: inhibitors of the synthesis and actions adrenocortical hormones, in: The Pharmacological Basis of Therapeutics, 8th edn., Vol. 8, eds. A. Goodman Gilman, T.W. Rall, A.S. Nies and P. Taylor (Macmillan Publishing Co., New York) p. 1431.
21. Ingrassia, R., G.F. Savoldi, A. Caraffini, M. Tironi, C. Poiesi, P. Williams, A. Albertini and D. Di Lorenzo, 1994, Characterization of a novel transcription complex required for glucocorticoid regulation of the rat alpha-1-acid glycoprotein gene, DNA Cell Biol. 13, 615.
22. Lazar, G.J., E. Duda and G. Lazar, 1992, Effect of RU 38486 on TNF production and toxicity, FEBS Lett. 308, 137.
23. Lipton, J.M., A. Macaluso, M.E. Hiltz and A. Catania, 1991, Central administration of the peptide α-MSH inhibits inflammation in the skin, Peptides 12, 795.
24. A receptor. Mechanism of action and physiological significance, Progr. Neurobiol. 38, 379.
25. May, M., E. Holmes, W. Rogers and M. Poth, 1990, Protection from glucocorticoid induced involution by dehydroepiandrosterone, Life Sci. 46, 1627.
26. Mengozzi, M., G. Fantuzzi, R. Faggioni, A. Marchant, M. Goldman, S. Orencole, B.D. Clark, M. Sironi, F. Benigni and P. Ghezzi, 1994, Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates interleukin 10 production in mice, Immunology 82, 207.
27. Paul, S.M. and R.H. Purdy, 1992, Neuroactive steroids, FASEB J. 6, 2311.
28. Schofield, P.R., M.G. Darlinson, N. Fujita, D.R. Burt, F.A. Stephenson, H. Rodriguez, L.M. Rhee, J. Ramachandran, V. Reale, J.A. Glencorse, P.H. Seeburg and E.A. Barnard, 1987, Sequence and functional expression of the GABAA receptor shows a ligand-gated receptor superfamily, Nature 328, 221.
29. Shafagoy, Y., J. Opoku, D. Qureshi, W. Regelson and M. Kalimi, 1992, Dehydroepiandrosterone prevents dexamethasone-induced hyperthension in rats, Am. J. Physiol. 263, E210.
30. Sironi, M., M. Gadina, M. Kankova, F. Riganti, A. Mantovani, M. Zandalasini and P. Ghezzi, 1992, Differential sensitivity of in vivo TNF and IL-6 production to modulation by antiinflammatory drugs in mice, Int. J. Immunopharmacol. 14, 1045.
31. Wang, A.M., A.A. Creasey, M.B. Ladner, J. Srickler, J.N. Van Arsdell, R. Yamamoto and D.F. Mark, 1985, Molecular cloning of the complementary DNA for human tumor necrosis factor, Science 228, 149.
32. Zavala, F., V. Taupin and B. Descamps-Latscha, 1990, In vivo treatment with benzodiazepines inhibits murine phagocyte oxidative metabolism and production of interleukin 1, tumor necrosis factor and interleukin 6, J. Pharmacol. Exp. Ther. 255, 442.